Sakata Naoaki, Yoshimatsu Gumpei, Tsuchiya Haruyuki, Aoki Takeshi, Mizuma Masamichi, Motoi Fuyuhiko, Katayose Yu, Kodama Tetsuya, Egawa Shinichi, Unno Michiaki
Division of Hepato-Biliary-Pancreatic Surgery; Department of Surgery; Tohoku University Graduate School of Medicine; Sendai, Japan.
Division of Hepato-Biliary-Pancreatic Surgery; Department of Surgery; Tohoku University Graduate School of Medicine; Sendai, Japan; Division of Integrated Surgery and Oncology; Tohoku University Graduate School of Medicine; Sendai, Japan.
Islets. 2013 Sep-Dec;5(5):179-87. doi: 10.4161/isl.26980. Epub 2013 Nov 14.
While islet transplantation is considered a useful therapeutic option for severe diabetes mellitus (DM), the outcome of this treatment remains unsatisfactory. This is largely due to the damage and loss of islets in the early transplant stage. Thus, it is important to monitor the condition of the transplanted islets, so that a treatment can be selected to rescue the islets from damage if needed. Recently, numerous trials have been performed to investigate the efficacy of different imaging modalities for visualizing transplanted islets. Positron emission tomography (PET) and magnetic resonance imaging (MRI) are the most commonly used imaging modalities for this purpose. Some groups, including ours, have also tried to visualize transplanted islets by ultrasonography (US). In this review article, we discuss the recent progress in islet imaging.
Front Endocrinol (Lausanne). 2021
Diabetes Metab Res Rev. 2011-11
Front Endocrinol (Lausanne). 2018-1-22
Diabetes Metab Syndr Obes. 2020-9-23
World J Diabetes. 2015-6-25
Contrast Media Mol Imaging. 2012
Diabetes Metab Res Rev. 2012-5